You are here: Industry Insights > cancer drug

News List

Novartis, Pfizer, AZ and more hand China 50%-plus cancer drug discounts fiercepharma
October 11, 2018
China is quickly approving many of the newest cancer drugs but it also is demanding big discounts if drugmakers want them on its national insurance coverage list.
AbbVie and Janssen announce failure of cancer drug Imbruvica in Phase 3 trial pharmafile
July 17, 2018
AbbVie and Janssen have announced that Imbruvica (ibrutinib) failed to achieve the primary endpoint in a late-stage study assessing its use in patients with treatment-naïve diffuse large B-cell lymphoma, an aggressive form of non-Hodgkin lymphoma.
Pfizer’s breast cancer drug combo falls short of survival goal financialexpress
June 29, 2018
Ibrance is Pfizer’s blockbuster treatment and is already approved as a combination with endocrine therapy for use in breast cancer patients
AstraZeneca, Merck eye $1 billion boost from cancer drug success financialexpress
June 29, 2018
The result should pave the way for expanded use of the medicine, which is being developed and marketed with Merck & Co under a deal struck last year
Cancer drug helps treat tuberculosis by restoring leaky blood vessels europeanpharmaceuticalreview
May 02, 2018
Drug that strengthens blood vessels allows antibiotics to infiltrate tuberculosis granulomas in mice…
FDA demand puts Compugen’s solid tumor checkpoint trial on ice fiercepharma
April 28, 2018
The FDA has temporarily blocked Compugen’s plans to start a phase 1 trial of PVRIG-targeting cancer drug COM701.
Cancer drug study placed on hold after patient death pharmatimes
March 14, 2018
US regulators have placed on hold a clinical trial testing a combination of Advaxis’ axalimogene filolisbac and AstraZeneca's Imfinzi after a patient died from respiratory failure.
PTT to establish production plant for cancer drug biospectrumasia
January 29, 2018
The plant will produce drugs for traditional chemotherapy in the form of injections and pellets.
Merck to submit CDF proposal for cancer drug pharmaceutical-technology
November 30, 2017
The UK National Institute for Health and Care Excellence (NICE) has invited Merck to submit a Cancer Drugs Fund (CDF) proposal for its immunotherapy, avelumab, for the treatment of patients with Merkel cell carcinoma (MCC).
Roche gives free access to cancer drug after Greek government altercation biospectrumasia
November 09, 2017
Roche gives free access to cancer drug after Greek government altercation The Greek government had introduced a levy of up to 25% on the turnover generated by patent-protected drugs as part of an ongoing bailout deal with international lenders.

Previous page 1 2 3 4 5 6 Next page